Diabetes, Vol 46, Issue 11 1792-1798, Copyright © 1997 by American Diabetes Association

ARTICLES

Inhibition of food intake by neuropeptide Y Y5 receptor antisense oligodeoxynucleotides

AO Schaffhauser, A Stricker-Krongrad, L Brunner, F Cumin, C Gerald, S Whitebread, L Criscione and KG Hofbauer
Metabolic and Cardiovascular Research, Novartis Pharma Basel, Switzerland.

The recently discovered rat neuropeptide Y (NPY) receptor, the Y5 subtype, has been proposed to mediate the NPY-induced feeding response and therefore plays a central role in the regulation of food intake. These conclusions were based on studies with peptidic agonists. We now report studies in which phosphothioate end-protected antisense oligodeoxynucleotides (ODNs) targeted to prepro NPY (prepro NPY antisense ODNs) or to the Y5 receptor (Y5 antisense ODNs) were used to assess the functional importance of this novel receptor subtype in vivo. NPY antisense ODNs given intracerebroventricularly to rats prevented the increase in hypothalamic NPY levels during food deprivation and inhibited fasting-induced food intake. Likewise, repeated intracerebroventricular injections of Y5 antisense ODNs prevented fasting-induced food intake in rats. Moreover, two Y5 antisense ODNs, targeted to different sequences of the receptor, significantly decreased basal food intake and inhibited the increase in food intake after intracerebroventricular injection of NPY. These effects proved to be selective, since the feeding response to galanin was not affected. Analysis of the structure of feeding behavior revealed that prepro NPY and Y5 receptor antisense ODNs reduced food intake by inducing decreases in meal size and meal duration analogous to the orexigenic effects of NPY that are mediated by increases in these parameters. Although changes in Y5 receptor density could not be measured, the results with Y5 antisense ODNs strongly suggest that this receptor subtype mediates the feeding response to exogenous and endogenous NPY. Selective Y5 antagonists may therefore be of therapeutic value for the treatment of obesity and eating disorders.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				M. M. Kamiji and A. Inui Neuropeptide Y Receptor Selective Ligands in the Treatment of Obesity Endocr. Rev., October 1, 2007; 28(6): 664 - 684. [Abstract] [Full Text] [PDF]

				S. Stanley, K. Wynne, B. McGowan, and S. Bloom Hormonal Regulation of Food Intake Physiol Rev, October 1, 2005; 85(4): 1131 - 1158. [Abstract] [Full Text] [PDF]

				J. Trevaskis, K. Walder, V. Foletta, L. Kerr-Bayles, J. McMillan, A. Cooper, S. Lee, K. Bolton, M. Prior, R. Fahey, et al. Src Homology 3-Domain Growth Factor Receptor-Bound 2-Like (Endophilin) Interacting Protein 1, a Novel Neuronal Protein that Regulates Energy Balance Endocrinology, September 1, 2005; 146(9): 3757 - 3764. [Abstract] [Full Text] [PDF]

				K. Wynne, S. Stanley, B. McGowan, and S. Bloom Appetite control J. Endocrinol., February 1, 2005; 184(2): 291 - 318. [Abstract] [Full Text] [PDF]

				J. D. Coppola, B. A. Horwitz, J. Hamilton, and R. B. McDonald Expression of NPY Y1 and Y5 receptors in the hypothalamic paraventricular nucleus of aged Fischer 344 rats Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2004; 287(1): R69 - R75. [Abstract] [Full Text] [PDF]

				J. W. Hill and J. E. Levine Abnormal Response of the Neuropeptide Y-Deficient Mouse Reproductive Axis to Food Deprivation But Not Lactation Endocrinology, May 1, 2003; 144(5): 1780 - 1786. [Abstract] [Full Text] [PDF]

				M. M. Berglund, P. A. Hipskind, and D. R. Gehlert Recent Developments in Our Understanding of the Physiological Role of PP-Fold Peptide Receptor Subtypes Experimental Biology and Medicine, March 1, 2003; 228(3): 217 - 244. [Abstract] [Full Text] [PDF]

				R. E. Campbell, M. S. Smith, S. E. Allen, B. E. Grayson, J. M. H. ffrench-Mullen, and K. L. Grove Orexin Neurons Express a Functional Pancreatic Polypeptide Y4 Receptor J. Neurosci., February 15, 2003; 23(4): 1487 - 1497. [Abstract] [Full Text] [PDF]

				A. V. Turnbull, L. Ellershaw, D. J. Masters, S. Birtles, S. Boyer, D. Carroll, P. Clarkson, S. J.G. Loxham, P. McAulay, J. L. Teague, et al. Selective Antagonism of the NPY Y5 Receptor Does Not Have a Major Effect on Feeding in Rats Diabetes, August 1, 2002; 51(8): 2441 - 2449. [Abstract] [Full Text] [PDF]

				N. Pronchuk, A. G. Beck-Sickinger, and W. F. Colmers Multiple NPY Receptors Inhibit GABAA Synaptic Responses of Rat Medial Parvocellular Effector Neurons in the Hypothalamic Paraventricular Nucleus Endocrinology, February 1, 2002; 143(2): 535 - 543. [Abstract] [Full Text] [PDF]

				F. Zammaretti, G. Panzica, and C. Eva Fasting, Leptin Treatment, and Glucose Administration Differentially Regulate Y1 Receptor Gene Expression in the Hypothalamus of Transgenic Mice Endocrinology, September 1, 2001; 142(9): 3774 - 3782. [Abstract] [Full Text] [PDF]

				M. Shimizu-Albergine, D. L. Ippolito, and J. A. Beavo Downregulation of Fasting-Induced cAMP Response Element-Mediated Gene Induction by Leptin in Neuropeptide Y Neurons of the Arcuate Nucleus J. Neurosci., February 15, 2001; 21(4): 1238 - 1246. [Abstract] [Full Text] [PDF]

				A. Kanatani, S. Mashiko, N. Murai, N. Sugimoto, J. Ito, T. Fukuroda, T. Fukami, N. Morin, D. J. MacNeil, L. H. T. Van der Ploeg, et al. Role of the Y1 Receptor in the Regulation of Neuropeptide Y-Mediated Feeding: Comparison of Wild-Type, Y1 Receptor-Deficient, and Y5 Receptor-Deficient Mice Endocrinology, March 1, 2000; 141(3): 1011 - 1016. [Abstract] [Full Text] [PDF]

				A. Inui Transgenic Approach to the Study of Body Weight Regulation Pharmacol. Rev., March 1, 2000; 52(1): 35 - 62. [Abstract] [Full Text] [PDF]

				P. J. Larsen, M. Tang-Christensen, C. E. Stidsen, K. Madsen, M. S. Smith, and J. L. Cameron Activation of Central Neuropeptide Y Y1 Receptors Potently Stimulates Food Intake in Male Rhesus Monkeys J. Clin. Endocrinol. Metab., October 1, 1999; 84(10): 3781 - 3791. [Abstract] [Full Text] [PDF]

				P. D. Raposinho, P. Broqua, D. D. Pierroz, A. Hayward, Y. Dumont, R. Quirion, J.-L. Junien, and M. L. Aubert Evidence That the Inhibition of Luteinizing Hormone Secretion Exerted by Central Administration of Neuropeptide Y (NPY) in the Rat Is Predominantly Mediated by the NPY-Y5 Receptor Subtype Endocrinology, September 1, 1999; 140(9): 4046 - 4055. [Abstract] [Full Text]

				M. W Schwartz, D. G Baskin, K. J Kaiyala, and S. C Woods Model for the regulation of energy balance and adiposity by the central nervous system Am. J. Clinical Nutrition, April 1, 1999; 69(4): 584 - 596. [Abstract] [Full Text] [PDF]

				L. Sun and R. J. Miller Multiple Neuropeptide Y Receptors Regulate K+ and Ca2+ Channels in Acutely Isolated Neurons From the Rat Arcuate Nucleus J Neurophysiol, March 1, 1999; 81(3): 1391 - 1403. [Abstract] [Full Text] [PDF]

				S. P. Kalra, M. G. Dube, S. Pu, B. Xu, T. L. Horvath, and P. S. Kalra Interacting Appetite-Regulating Pathways in the Hypothalamic Regulation of Body Weight Endocr. Rev., February 1, 1999; 20(1): 68 - 100. [Abstract] [Full Text]

				S. Pu, M. R. Jain, T. L. Horvath, S. Diano, P. S. Kalra, and S. P. Kalra Interactions between Neuropeptide Y and {gamma}-Aminobutyric Acid in Stimulation of Feeding: A Morphological and Pharmacological Analysis Endocrinology, February 1, 1999; 140(2): 933 - 940. [Abstract] [Full Text]

				Y. Dumont, A. Fournier, and R. Quirion Expression and Characterization of the Neuropeptide Y Y5 Receptor Subtype in the Rat Brain J. Neurosci., August 1, 1998; 18(15): 5565 - 5574. [Abstract] [Full Text] [PDF]

				C. Cabrele, M. Langer, R. Bader, H. A. Wieland, H. N. Doods, O. Zerbe, and A. G. Beck-Sickinger The First Selective Agonist for the Neuropeptide YY5 Receptor Increases Food Intake in Rats J. Biol. Chem., November 10, 2000; 275(46): 36043 - 36048. [Abstract] [Full Text] [PDF]